MISSISSAUGA, ON, Feb. 4, 2021 – Eisai Limited, the Canadian subsidiary of Eisai Inc., today announced the Canadian authorization and availability of a new non-sedative prescription medication, DAYVIGO™ (lemborexant).  Available … Continue reading Health Canada authorizes DAYVIGO (lemborexant) for treatment of insomnia